Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States
2017 ◽
Vol 20
(7)
◽
pp. 692-702
◽
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 56
(10)
◽
pp. 1382-1393
◽
Keyword(s):
2019 ◽
Vol 20
(3)
◽
pp. 251-257
Keyword(s):
2002 ◽
Vol 97
(3)
◽
pp. 721-728
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):